Minerva Surgical, Inc. (UTRS) stock remained unchanged at $0.00 a share on NASDAQ. The stock opened at $0.00, fluctuating between $0.00 to $0.00 during the session.
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Employees | 174 |
Beta | 4.6 |
Sales or Revenue | $50.29M |
5Y Sales Change% | 0% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Healthcare Information Services |
Minerva Surgical, Inc. (NASDAQ: UTRS) stock price is $0.00 in the last trading session. During the trading session, UTRS stock reached the peak price of $0.00 while $0.00 was the lowest point it dropped to. The percentage change in UTRS stock occurred in the recent session was 0% while the dollar amount for the price change in UTRS stock was -.
The NASDAQ listed UTRS is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector. Minerva Surgical, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Kaile Zagger
Chief Commercial Officer
Mr. David M. Clapper
Pres, Chief Executive Officer & Director
Mr. Todd Usen
Pres, Chief Executive Officer & Director
Dr. Evgueni V. Skalnyi M.D.
Chief Medical Officer
Mr. Joel R. Jung MBA
Chief Financial Officer
Mr. Thomas Pendlebury
Vice President of Sales & Marketing
Mr. Dominique J. Filloux
Chief Operating Officer
Ms. Joanne Long
Vice President of Corporation Controller
Ms. Wendy Bowman
Vice President of HR
UTRS's closing price is 0% higher than its 52-week low of $0.00 where as its distance from 52-week high of $0.97 is -99.99%.
Number of UTRS employees currently stands at 174.
Official Website of UTRS is: https://minervasurgical.com
UTRS could be contacted at phone 855 646 7874 and can also be accessed through its website. UTRS operates from 4255 Burton Drive, Santa Clara, CA 95054, United States.
UTRS stock volume for the day was 140 shares. The average number of UTRS shares traded daily for last 3 months was 101.
The market value of UTRS currently stands at $888.00 with its latest stock price at $0.00 and 8.88M of its shares outstanding.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com